Gopal Natesan | Medicinal Chemistry | Best Researcher Award


Warning: Undefined variable $insensitive in /home/u792129758/domains/sciencefather.com/public_html/academicawards/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 201

Warning: Undefined variable $insensitive in /home/u792129758/domains/sciencefather.com/public_html/academicawards/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 202

Prof Dr. Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Prof Dr. Gopal Natesan, Institute of Pharmacy, Nirma University, India

Prof. Dr. Gopal Natesan is a distinguished academic and researcher in pharmaceutical chemistry, currently serving as Professor & Director at the Institute of Pharmacy, Nirma University, India. He holds a Ph.D. from Hamdard University and an MBA from MAHSA University. His research focuses on the synthesis of biologically active compounds and pharmacological evaluations. Dr. Natesan has received numerous accolades, including the “Most Trusted & Innovative Researcher in Asia” award in 2023 and the “Outstanding Scientist Award” in 2022. With a strong industrial background, he promotes research innovation and academic excellence. πŸ§ͺπŸ“š

Publication profile

Educational Qualifications

Prof. Dr. Gopal Natesan boasts an impressive educational background. He earned his Ph.D. in Pharmaceutical Chemistry from Hamdard University in 2001. He also holds an M. Pharmacy from JSS College of Pharmacy (1996) and a B. Pharmacy from JKK Nataraja College of Pharmacy (1993), both affiliated with The Tamilnadu Dr. MGR Medical University. In 2016, he completed a Post Graduate Certificate in Teaching & Learning at Anglia Ruskin University, UK, and became a Fellow of The Higher Education Academy. Most recently, he obtained an MBA from MAHSA University in 2022. πŸ“šπŸ”¬

 

Honors & Awards

Prof. Dr. Gopal Natesan has received numerous prestigious awards for his contributions to pharmaceutical science and education. In 2023, he was honored as the “Most Trusted & Innovative Researcher in Asia” at the ASIA-GCC Awards. His accolades include the “Outstanding Scientist Award” in 2022 and the “Edward Kennedy Memorial Award” in 2017. He has also received multiple best presentation and paper awards at international conferences, reflecting his commitment to excellence in research. Additionally, he was recognized with a Vice-Chancellor Award for outstanding performance in his MBA program, showcasing his academic prowess. πŸŒŸπŸŽ“

 

Employment History

Prof. Dr. Gopal Natesan has served as Professor and Director at the Institute of Pharmacy, Nirma University, Ahmedabad, India. In this role, he manages operational activities, ensuring efficient administration and resource utilization. He oversees academic programs, maintaining high standards in teaching and curriculum development. Dr. Natesan is dedicated to faculty development, fostering continuous learning and research engagement. He enhances student experiences through support services and extracurricular activities while ensuring quality assurance through compliance with academic standards. Additionally, he promotes research innovation by securing grants and encouraging collaborations with industry and academia. πŸŒŸπŸ”¬

Industrial Experience

Prof. Dr. Gopal Natesan has valuable industrial experience in the pharmaceutical sector. From November 2000 to January 2002, he worked as a Research Scientist at Ranbaxy Research Laboratory in Gurgoan, New Delhi, where he contributed to innovative pharmaceutical research. Following this, he served as a Research Associate at Orchid Chemicals & Pharmaceuticals Ltd in Chennai from January 2002 to February 2004. In these roles, he developed essential skills in research methodologies and project management, further enhancing his expertise in medicinal chemistry and pharmaceutical sciences. His industrial background complements his academic leadership, bridging theory and practice. πŸ’Όβœ¨

 

Research Interests

Prof. Dr. Gopal Natesan specializes in medicinal chemistry, focusing on the synthesis and characterization of biologically active new chemical entities with five or six-member heterocyclic ring systems. His research includes the pharmacological evaluation of synthesized compounds, ensuring their potential therapeutic applications. Additionally, he is dedicated to the isolation and characterization of active constituents from plant sources, highlighting the importance of natural products in drug discovery. Dr. Natesan also explores pharmaceutical marketing management, integrating scientific research with practical applications in the pharmaceutical industry. πŸŒ±πŸ’Š

 

Publication Top Notes Β 

 

  • Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats – Cited by: 85, Year: 2008 πŸ“„
  • Simultaneous estimation of paracetamol and aceclofenac in combined dosage forms by RP-HPLC method – Cited by: 44, Year: 2007 πŸ’Š
  • Synthesis and Antibacterial Activity of Some Imidazole‐5‐(4H)one Derivatives – Cited by: 32, Year: 2005 🦠
  • Synthesis, characterization and antimicrobial activity of some novel Schiff and Mannich bases of isatin – Cited by: 22, Year: 2014 ✨
  • Antipyretic and analgesic effects of the aqueous extracts of Prosopis cineraria – Cited by: 22, Year: 2011 🌿
  • Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method – Cited by: 19, Year: 2012 πŸ’Š
  • Simultaneous estimation of levocetirizine, ambroxol, phenylpropanolamine and paracetamol in combined dosage forms by RP-HPLC method – Cited by: 17, Year: 2006 πŸ“Š
  • Anti-inflammatory activity of newly synthesised N-[4’-Oxo-2’-(substituted aryl/heteryl)-thiazolidin-3’-yl]-3-carboxamido-2H-chromen-2-one derivatives – Cited by: 15, Year: 2011 πŸ”
  • UV-Spectrophotometric Determination of Esomeprazole in tablet dosage forms – Cited by: 14, Year: 2007 πŸ’‘
  • Effect of pollen substitute and two queen system on royal jelly production in Apis Mellifera L – Cited by: 13, Year: 1996 🐝
  • A validated HPTLC method for the estimation of donepezil HCL in bulk and its tablet dosage form – Cited by: 12, Year: 2011 βœ”οΈ
  • Synthesis and anticonvulsant activity of new 2-(substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-1, 2, 3, 4-tetrahydroquinazolin-4 (3H)-one derivatives – Cited by: 12, Year: 2006 ⚑
  • Synthesis and pharmacological evaluation of some indanone-3-acetic acid derivatives – Cited by: 11, Year: 2006 πŸ“ˆ
  • UV spectrophotometric determination of famciclovir – Cited by: 10, Year: 2007 πŸ“Š
  • Simultaneous determination of lafutadine and domperidone in capsule by high performance liquid chromatography – Cited by: 9, Year: 2012 πŸ’Ό